Switch to Efmoroctocog Alfa May Lower Bleeding Events in Hemophilia A
Patients in France with hemophilia A who switched their FVIII replacement treatment trended towards fewer bleeding events and articular non-bleeding events requiring hospitalization.
Marc Trossa Van Hinloopen University Hospital Of Nantes A Approach Using National Registries Hemophilia Treatment Centre National Des Donn
Source: hcplive.com